Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA approves BMS’s Zeposia for chronic inflammatory bowel disease

May 28, 2021
Medical Communications

The FDA has approved Approves Bristol Myers Squibb’s Zeposia for adults with moderately to severely active ulcerative colitis (UC). UC …

News
astrazeneca_sign_sky

EU: Fine AstraZeneca €10 per dose for COVID-19 vaccine delay

May 28, 2021
Medical Communications

The EU is suing AstraZeneca in a Brussels court over its failure to deliver on its vaccine contract. EU member …

News

NICE recommends Janssen’s active psoriatic arthritis drug

May 28, 2021
Medical Communications Janssen, NICE, UK, arthritis

NICE have released a Final Appraisal Document (FAD) recommending Janssen’s tremfya (guselkumab) as a new option for treating active psoriatic …

News

First COVID-fighting herbal supplement launched

May 27, 2021
COVID-19, herbal supplement

The first herbal supplement shown in clinical trials to prevent COVID-19 symptoms from deteriorating has been launched by Swiss Pharmacan …

News
gilead-sciences

Gilead to supply India one million doses of ‘black fungus’ medicine

May 27, 2021

Gilead Sciences are to supply one million doses of Amphotericin-B to India as black fungus (mucormycosis) cases surge. The drug …

News
janssen_latest_logo_on_sign_closer

Janssen sees promising PRO data for prostate cancer therapy

May 27, 2021
Janssen, prostate cancer

Janssen has announced patient-reported outcomes (PRO) data from the pre-specified final analysis of their Phase III TITAN study in patients …

News
sanofi_hq__boetie_hall_web

Sanofi-GSK Phase III trial begins for COVID-19 vaccine

May 27, 2021

Sanofi and GSK have begun their Phase III clinical study to assess the safety, efficacy, and immunogenicity of their COVID-19 …

News

Medical cannabis more effective painkiller in 86% of chronic pain patients

May 27, 2021
medical cannabis

The Medical Cannabis Clinics (TMCC) have released new data from a survey of patients prescribed medical cannabis to treat pain, …

News

Doctor vigilance urged for rare instances of stroke following COVID-19 vaccinations

May 26, 2021
Research and Development

Doctors have been urged to be vigilant for signs of stroke after three rare instances have occurred in Oxford-AstraZeneca patients. …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

May 26, 2021
Research and Development

The past week has seen lots of positive COVID-19 news; a French study has found that dogs can detect COVID-19 …

News

Australian study sees 70% HPV reduction in gay and bisexual men

May 26, 2021
Research and Development Australia, HPV, Vaccine

A school-based human papillomavirus (HPV) vaccination study programme, led by Monash University and Alfred Health, found a 70% reduction in …

News
moderna_norwood_plant

Moderna vaccine shows 100% efficacy in teens

May 26, 2021
Research and Development

Moderna’s TeenCOVE study, involving 3,700 adolescents aged 12 to less than 18 years old, observed no cases of COVID-19 after …

News
andrei_r_-_shutterstock_1935537274_720

Ori Biotech and Vineti to collaborate on CGT manufacturing

May 26, 2021
Research and Development AI, CGTs

Ori Biotech and Vineti have announced a strategic partnership to produce pre-integrated solutions to fast-track and streamline the manufacture and …

News

NICE recommends inducing woman in labour earlier than previously advised

May 25, 2021
Manufacturing and Production

In new draft guidance published today NICE has recommended that inducing women in labour earlier than previously advised will make …

News
takeda_usa_pharmaceuticals_u

Takeda: Dengue vaccine successful in long-term trials & set for global distribution

May 25, 2021
Manufacturing and Production EMA, Vaccine, dengue

Japanese pharma company Takeda has announced long-term safety and efficacy results for its dengue vaccine candidate, TAK-003, and has successfully …

News

Man’s eyesight partially restored with optogenetic therapy

May 25, 2021
Manufacturing and Production

A man in France has had his eyesight restored after 20 years of complete blindness, in the first reported case …

News

New research begins on producing HIV treatments in plants

May 25, 2021
Manufacturing and Production

St George’s, University of London has announced a partnership with Leaf Expression Systems to produce HIV treatments in plants. The …

News

CMA to review AstraZeneca’s $39 billion buyout of Alexion

May 25, 2021
Manufacturing and Production

The UK’s Competition and Markets Authority (CMA) is to review AstraZeneca’s $39 billion buyout of US-based Alexion Pharmaceuticals. The COVID-19 …

News

CDC investigating post-vaccine inflammation reports in the US

May 24, 2021
Sales and Marketing

The US Centers for Disease Control (CDC) is looking in to a small number of reports that some young vaccine …

News

C. difficile infection Phase III trial meets primary endpoint

May 24, 2021
Sales and Marketing

Ferring Pharmaceuticals and Rebiotix have presented Phase III results demonstrating superior efficacy of investigational RBX2660 in reducing recurrence of Clostridioides …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026